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Abstract  
 
Background. Tissue factor (TF) is an important trigger of arterial thrombosis. 
The green tea catechin epigallocatechin-3-gallate (EGCG) is a ligand of the 67 
kDa laminin receptor (67LR) and exhibits cardioprotective effects. This study 
investigates whether 67LR regulates TF expression in human endothelial cells. 
Methods and Results. Immunofluorescence demonstrated that human aortic 
endothelial cells expressed 67LR. Cells grown on laminin expressed 35% less 
TF in response to TNF-alpha (TNF-α) than those grown on fibronectin (n=6; 
p<0.001). EGCG (1-30 µM) inhibited TNF-α and histamine induced endothelial 
TF expression and activity in a concentration dependent manner resulting in 
87% reduction of TF expression (n=5; p<0.001); in contrast, expression of 
tissue factor pathway inhibitor was not affected (n=4; p=NS). In vivo 
administration of EGCG (30 mg/kg/d) inhibited TF activity in carotid arteries of 
C57BL6 mice. Real-time PCR and promoter studies revealed that EGCG 
decreased TF expression at the transcriptional level and impaired activation of 
the mitogen activated protein (MAP) kinase JNK 1/2, but not ERK or p38.  
Similarly, the JNK 1/2 inhibitor SP600125 (1 μM) impaired TF promoter activity 
(n=4; p<0.001) and protein expression (n=4; p<0.001). 67LR blocking 
antibodies blunted the inhibitory effect of EGCG on both TF protein expression 
and JNK activation. In contrast, vascular cell adhesion molecule 1 (VCAM-1) 
was not affected by laminin nor EGCG, and its expression was not regulated by 
JNK. EGCG did not affect TNF-α stimulated NFkB activation. 
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Conclusions. Laminin receptor activation inhibits endothelial TF expression by 
impairing JNK phosphorylation. Thus, 67LR may be a potential target for the 
development of novel anti-thrombotic therapies.  
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Introduction 
 
Tissue factor (TF) plays an important role in initiating coagulation [1]. 
Inflammatory mediators such as TNF-alpha (TNF-α) or histamine are potent 
inducers of TF expression in vascular cells [2]. Elevated levels of TF are 
detected in atherosclerotic plaques, and an involvement of TF in drug-eluting 
stent thrombosis has been discussed as well [3,4]. These findings suggest that 
modulation of TF expression in vascular cells may offer a strategy for the 
treatment and prevention of arterial thrombosis. 
The extracellular matrix (ECM) plays a pivotal role in vascular 
homeostasis, since it maintains vascular integrity by regulating proliferation, 
migration, and morphogenesis of endothelial cells [5,6]. Indeed, the basement 
membrane forms a scaffold around the endothelial tube, and interactions 
between endothelial cells and constituents of the basement membrane are 
essential for vessel wall integrity [7]. The non-collagenous glycoprotein laminin 
is a cross shaped heterotrimer of α, β, and γ subunits and a major component 
of the basement membrane [7]. The membrane bound 67 kDa-laminin receptor 
(67LR) is a non-integrin cell surface receptor directly interacting with the β1 
subunit of laminin [8]. Besides its role in cell adherence to the extracellular 
matrix, there is growing evidence that 67LR activation induces functional 
changes within cells [8]. 67LR has indeed been implicated in shear stress 
induced endothelial nitric oxide synthase (eNOS) activation, since its blockade 
abolished shear induced eNOS phosphorylation [9]. Despite such observations, 
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the role of 67LR in endothelial activation remains incompletely understood, and 
possible implications for arterial thrombosis have not been investigated.  
Recently, 67LR has been identified as a cell surface receptor for the 
green tea polyphenol epigallocatechin-3-gallate (EGCG) [10]. EGCG is the most 
abundant polyphenol found in green tea and constitutes 30% of its dry mass. 
Experimental studies revealed cardioprotective properties of ECGC consisting 
in anti-inflammatory, anti-oxidant, and anti-atherogenic effects [11-16]; 
moreover, large epidemiological trials demonstrated that green tea consumption 
is inversely associated with cardiovascular mortality [17-19]. 
The present study investigates whether 67LR modulates TF expression 
in human aortic endothelial cells.  
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Methods 
 
Cell culture 
Human aortic endothelial cells (HAEC; Clonetics, Allschwil, Switzerland), 
human umbilical venous endothelial cells (HUVEC; Clonetics) and human aortic 
vascular smooth muscle cells (HASMC, Clonetics) were cultured on fibronectin 
as described [20]. Cells were rendered quiescent in medium supplemented with 
0.5% fetal bovine serum for 24 hours before stimulation with 5 ng/mL TNF-α 
(R&D Systems, Minneapolis, MN) or 10 μM histamine (Sigma, St. Louis, MO). 
Cells were pretreated with EGCG (Sigma) for 60 minutes. For studies of VCAM-
1 and TF protein expression HAEC were stimulated for 5 hours. To block the 
mitogen activated protein (MAP) kinase c-Jun terminal NH2 kinase 1/2 (JNK 
1/2), HAEC were treated with SP600125 (Calbiochem, Lucerne, Switzerland) for 
60 minutes before stimulation. Cytotoxicity was assessed using a colorimetric 
assay for detection of lactate dehydrogenase release (Roche, Basel, 
Switzerland). Where mentioned, dishes were coated with laminin (25 µg/mL; 
Sigma). To compensate for the slower growth rates of HAEC on laminin as 
compared to fibronectin, a higher cell number was seeded on the dishes; the 
two groups exhibited similar confluency at the time of the experiments. To study 
the role of 67LR, cells were pretreated for 60 minutes with either a monoclonal 
(MLuC5, 1:1’000) or a polyclonal (ab711, 1:1’000) anti-human 67LR blocking 
antibody or the appropriate isotype antibodies (all from Abcam, Cambridge, 
UK).  
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Immunofluorescence microscopy 
HAEC were grown on LabTek chamber slides (Nunc, Rochester, MN), 
washed three times with PBS, and fixed with 4% paraformaldehyde for 15 min. 
Cells were washed twice with PBS and incubated with anti-67LR (MLuC5) 
antibody for 1 hour (1:1’000), followed by incubation with Alexa-488 conjugated 
secondary antibody (Invitrogen, Carlsbad, CA) for 1 hour (1:2’000). Antibodies 
were diluted in PBS containing 1% bovine serum albumin. After washing with 
PBS, cells were counterstained with 4',6-diamidino-2-phenylindole (DAPI) 
(Vector Laboratories Inc., Burlingame, CA), mounted on chamber slides, and 
examined by a fluorescence microscope (Olympus, DP40, Tokyo; Japan).  
 
Western blot 
Protein expression was determined by Western blot analysis. Antibodies 
against human TF, tissue factor pathway inhibitor (TFPI) (both from American 
Diagnostica, Stamford, CT), and vascular cell adhesion molecule-1 (VCAM-1; 
R&D Systems, Minneapolis, MN) were used at 1:2500 dilution. Antibodies 
against phosphorylated p38 MAP kinase (p38), p44/42 MAP kinase 
(extracellular signal regulated kinase [ERK]), and c-Jun NH2 terminal kinase 
(JNK1/2; all from Cell Signaling, Danvers, MA) were used at 1:1000, 1:5000, 
and 1:1000 dilution, respectively. Antibodies against total p38, ERK, and 
JNK1/2 (all from Cell Signaling) were used at 1:2000, 1:5000, and 1:1000 
dilution, respectively. IkB-α expression pattern was assessed by anti-human 
IkB-α antibody (1:5000; Cell Signaling). All blots were normalized to 
glyceraldehyde 3-phosphate dehydrogenase (GAPDH) expression (1:10’000 
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dilution, Chemicon International, Temecula, CA). The quantification of protein 
was performed by densitometric analysis using Scion Image Software (Scion 
Corp., Frederick, MD). 
 
TF surface activity 
TF surface activity was analyzed on HAEC after 5 hours of stimulation 
with TNF-α in the presence or absence of EGCG (30 μM) using a colorimetric 
assay (American Diagnostica). Briefly, TF/FVIIa complex converted human 
factor X to factor Xa, which was measured by its ability to metabolize a 
chromogenic substrate. The absorbance of the reaction mixture was measured 
at 405 nm, and TF activity was determined from a standard curve performed 
with lipidated human TF. 
 
In vivo study 
Analysis of TF activity was performed in 10 week old male C57BL6 mice 
(Jackson Laboratories, Bar Harbor, ME) weighing an average of 26 g and fed a 
normal chow diet (KLIBA NAFAG, Kaiseraugst, Switzerland). EGCG was 
dissolved in PBS (pH 7.4) and administrated i.p. at a dose of 30 mg/kg/d for 7 
days. Age, sex, and weight matched controls received an equal volume of 
vehicle. Mice were then euthanized and the left common carotid artery 
harvested for analysis of TF activity using a colorimetric assay (American 
Diagnostica). 
 
Real-time PCR 
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RNA was extracted from HAEC using TRIzol Reagent (Invitrogen, 
Carlsbad, CA) and real-time PCR performed as described [20]. The following 
primers were used: for full length human TF (F3): sense 5’-
TCCCCAGAGTTCACACCTTACC–3’ (bases 508-529 of F3 cDNA; NCBI no. 
NM 001993), antisense 5’–CCTTTCTCCTGGCCCATACAC–3’(bases 843-863 
of F3 cDNA; NCBI no. NM 001993); for human ribosomal L28: sense 5’-
GCATCTGCAATGGATGGT-3’, antisense 5’–CCTTTCTCCTG-GCCCATACAC-
3’. Melting curve analysis was performed after amplification to verify the 
accuracy of the amplicon, and PCR products were analyzed on an ethidium 
bromide stained 1% agarose gel. In each real-time PCR run for TF and L28, a 
standard curve generated from serial dilutions of purified amplicons was 
included.  
 
TF promoter activity 
TF promoter activity was measured as described [21]. Briefly, the 
minimal TF promoter (-227 bp to +121 bp) was cloned upstream of the firefly 
luciferase reporter gene using a pGL2-Basic plasmid (Promega, Madison, WI). 
For transduction, the adenoviral vector Ad5/hTF/Luc was added to HAEC at an 
multiplicity of infection of 100 plaque forming units/cell for 1 hour and then 
removed. The adenoviral vector VQAd Empty was used as a negative control.  
HAEC were kept in growth medium for 24 hours and then serum starved for 24 
hours prior to TNF-α stimulation for 1 hour with or without EGCG (30 µM). 
Firefly luciferase activity was determined in cell lysates using a luminometer 
(Berthold Technologies, Bad Wildbad, Germany) and normalized by determing 
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protein concentration in the lysates. 
 
Transfection with siRNA 
HAEC were transfected with siRNA (15 nM) against JNK 1 (5’-
AAAGAAUGUCCUACCUUCUTT-3’), JNK 2 (5’-AGAAGGUAGGA-
CAUUCUUUTT-3’) or scrambled RNA (all from Sigma) using the N-TER™ 
Nanoparticle siRNA Transfection System (Sigma) for 4 hours. After transfection, 
HAEC were grown for 12 hours and then serum starved for 24 hours prior to the 
experiment. 
 
Nuclear extraction and NFkB activity assay 
For NFκB activity measurements, HAEC were stimulated with TNF-α for 
30 minutes in the presence or absence of EGCG (30 μM). Nuclear extracts 
were obtained from HAEC using a nuclear extraction kit (Active Motif, Carlsbad, 
USA). Nuclear protein (20 µg) was loaded in each well, and NFκB activity was 
measured using a TransAM NFkB p65 kit (Active Motif) according to 
manufacturer’s recommendations. 
 
Statistics 
Data are presented as mean±SEM. Statistical analysis was performed 
using two tailed unpaired Student´s t-test or one-way ANOVA as appropriate. A 
value of p<0.05 was considered significant. All results are representative of at 
least four independent experiments. 
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Results 
 
Laminin inhibits TF protein expression 
Immunofluorescence microscopy revealed that 67LR was abundantly 
expressed on the surface of HAEC (Figure 1A). Western blot analysis 
demonstrated that TNF-α (5ng/mL) induced TF expression was 35% lower in 
cells growing on laminin as compared to those growing on fibronectin (n=4; 
p<0.001; Figure 1B). 
 
67LR inhibits TF protein expression  
EGCG (1-30 µM) inhibited TNF-α (5 ng/mL) induced TF expression in a 
concentration dependent manner (n=5; *p<0.001; figure 2A); the maximal effect 
occurred at 30 µM and decreased TF expression by 87% as compared to TNF-
α alone. Similarly, EGCG (30 µM) inhibited histamine (10 µM) induced TF 
expression by 84% as compared to histamine alone (n=5; *p<0.001; figure 2B). 
EGCG did not affect expression of TFPI (n=4; p=NS; supplemental figure 1). 
The effect of EGCG on TF protein expression was paralleled by a reduced TF 
surface activity (n=4; *p<0.001; figure 2C). Further the effect of EGCG on TF 
activity was assessed in carotid artery lysates of C57BL6 mice. EGCG 
administrated for 7 days (30 mg/kg/d) reduced TF activity by 46.6±17% as 
compared to control animals (n=5; p<0.05; figure 2D). In line with this 
observation, EGCG also impaired TNF-α induced TF expression in cultured 
HASMC and HUVEC (n=4; p<0.01; supplemental figure 2 and 3). Pretreatment 
of HAEC with the monoclonal 67LR blocking antibody MLuC5 blunted the 
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inhibitory effect of EGCG on TF protein expression as compared to cells treated 
with the isotype control (n=4; *p<0.001 vs TNF-α alone; figure 2E). A similar 
effect was observed using a polyclonal 67LR antibody (n=4; *p<0.001; data not 
shown). LDH release was not altered by any of the EGCG concentrations used 
(n=4; p=NS; data not shown). 
 
67LR inhibits TF mRNA expression and promoter activity but not TNF-α 
induced NFkB activation  
TNF-α induced TF mRNA expression within 2 hours of stimulation as 
determined by real-time PCR analysis (n=5; *p<0.0001; Figure 3A). EGCG (30 
µM) impaired TNF-α induced TF mRNA expression by 74% as compared to 
TNF-α alone (n=5; *p<0.001; Figure 3A). EGCG (30 µM) did not alter TNF-α 
stimulated IkB-α degradation nor TNF-α induced nuclear translocation and DNA 
binding activity of the NF kappa B subunit p65 (n=4; p=NS, figure 3B and 3C). 
To assess whether the effect on TF mRNA was mediated via promoter 
inhibition, the impact of EGCG on TF promoter activity was analyzed after 
adenoviral transduction of endothelial cells with firefly luciferase under control of 
the human minimal TF promoter (-221 bp to +121 bp). TNF-α enhanced TF 
promoter activity by 2.2 fold as compared to control conditions (n=4; *p<0.001; 
Figure 3D); while EGCG (30 µM) inhibited this effect by 51% (n=4; *p<0.001; 
Figure 3D). 
 
67LR inhibits JNK1/2 phosphorylation  
To determine whether 67LR inhibited MAP kinases, phosphorylation of 
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these mediators was assessed at different time points after TNF-α stimulation. 
TNF-α (5 ng/mL) transiently activated JNK1/2, ERK, and p38; maximal 
activation was observed after 15 minutes and returned to basal levels within 60 
minutes (Figure 4A). EGCG inhibited phosphorylation of JNK by 46% as 
compared to TNF-α alone (n=4; *p<0.01; Figure 4B), while phosphorylation of 
ERK and p38 was not altered (n=4; p=NS; Figure 4B). Total expression of JNK 
1/2, ERK, and p38 remained unaffected at all time points examined (Figure 4A). 
Targeting of JNK1 and JNK2 with specific siRNA impaired TNF-α induced TF 
expression by 33% and 60%, respectively as compared to TNF-α alone (n=4; 
p<0.05 for JNK1 vs TNF- alone and p<0.01 for JNK2 vs TNF- alone; figure 
5A). Inhibition of JNK 1 and 2 phosphorylation with SP600125 mimicked  the 
effect of siRNA on TF protein expression (n=4; *p<0.001; Figure 5B) and 
abolished TNF-α induced TF promoter activation (n=4; *p<0.001; Figure 5C). 
The inhibitory effect of EGCG on JNK phosphorylation was prevented by 
pretreatment with the 67LR blocking antibody MLuC5 (n=3; p<0.01; Figure 5D). 
 
Neither 67LR nor JNK 1/2 regulate VCAM-1 expression 
Western blot analysis revealed that TNF-α induced VCAM-1 expression 
(n=4; p<0.001; Figure 5A) in HAEC. Neither 67LR activation by laminin or 
EGCG (1-30 μM) nor JNK inhibition by SP600125 (n=4; p=NS; Figure 6A, 6B, 
and 6C) impaired TNF-α induced VCAM-1 expression. Similar to the result 
obtained in HAEC with EGCG in HUVEC (n=4; p=NS; supplemental figure 4). 
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Discussion 
 
This study demonstrates that activation of the 67LR by laminin or EGCG 
inhibits TNF-α induced TF expression in endothelial cells. Moreover, 
administration of EGCG in C57BL6 mice diminishes TF activity in carotid artery 
lysates. This effect is mediated at the transcriptional level via reduced 
phosphorylation of the JNK isoforms p46 and p54 (JNK1 and JNK2) and 
impaired TF promoter activation. In contrast, 67LR does not affect the JNK 1/2 
independent expression of VCAM-1 in these cells.  
Endothelial cells line the vascular lumen while their abluminal surface 
interacts with the basal membrane. The laminin 10 isoform is the main 
component of the basal membrane in mature vessels, separating endothelial 
cells from interstitial collagens [7]. It is notable that the laminin most widely used 
for in vitro studies was isolated from mouse Engelberth-Holm-Swarm tumors 
corresponding to the laminin 1 isotype [7]. This form of laminin, however, does 
not occur in the endothelial cell basement membrane and therefore might 
constitute a limitation for previous studies. Therefore, the effect of laminin on 
TNF-α induced TF expression was analysed in this study using commercially 
available human laminin and mainly containing the laminin 10 isoform.  
Separation of endothelial cells from interstitial collagens plays an 
important role in maintaining vessel wall integrity, since laminin and interstitial 
collagen modulate endothelial function in a differential manner. Indeed, collagen 
activates endothelial Src kinase as well as the GTPase Rho while suppressing 
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the activity of the GTPase Rac, leading to disruption of intercellular junctions, 
cell proliferation, tube formation, and initiation of angiogenesis [5,6]. In contrast, 
laminin antagonizes these effects [5,6]. In line with these findings, cells growing 
on laminin proliferate slower than those on fibronectin. The present study 
demonstrates that endothelial cells growing on laminin express lower levels of 
TF upon stimulation with TNF-α as compared to those on fibronectin. This 
observation is consistent with the interpretation that basal membrane 
associated laminin preserves vascular integrity by reducing endothelial cell 
activation.  
The interaction between 67LR and the laminin subunit β1 is an essential 
component of cellular adhesion to the basement membrane [8]. The polyphenol 
EGCG has been characterized as a ligand for 67LR. Experiments performed in 
human lung cancer cells demonstrate that EGCG mediated growth inhibition is 
67LR dependent and that EGCG binds to the 67LR with a Kd value of 39.9 nM 
[10]. In endothelial cells, 67LR is involved in shear stress induced endothelial 
nitric oxide synthase activation, indicating that this receptor has functional 
properties beyond its known role in cell adherence [9]. The present study 
demonstrates that 67LR is abundantly expressed on the surface of human 
aortic endothelial cells and that activation of 67LR by laminin or EGCG inhibits 
TF protein expression and activity.  
TF expression is a major trigger of the thrombotic response, and high 
levels of TF contribute to thrombus formation following plaque rupture or 
erosion [4]. The proinflammatory cytokine TNF-α [22]  and histamine have been 
identified as potent inducers of TF expression [2]. Similar to laminin, EGCG 
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inhibited TNF-α and histamine induced TF expression in a concentration 
dependent manner. The MAP-kinases JNK1/2, p38, and ERK regulate TF 
expression at the transcriptional level in response to both agonists [23]. 67LR 
activation by EGCG resulted in decreased phosphorylation of the MAP kinase 
JNK1/2 and decreased expression of TF. Conversely, 67LR blockade abolished 
the inhibitory effects of EGCG on JNK1/2 activation and TF expression. Finally, 
specific targeting of JNK1/2 with siRNA or the pharmacological inhibitor 
SP600125 reduced TNF-α induced TF promoter activity, RNA and protein 
expression. Hence, EGCG inhibits TF expression by decreasing JNK activation.  
An involvement of MAP kinases in laminin signalling has been described 
in tumor cells [24]. To confirm the role of JNK1/2 in mediating the effects of 
67LR activation on endothelial TF, TNF-α induced VCAM-1 expression was 
analyzed, since this protein, is regulated independent of JNK1/2 in this cell type 
[25]. Neither laminin nor EGCG affected endothelial VCAM-1 expression, 
confirming that 67LR activation specifically inhibits JNK1/2. It is of note that 
some previous studies described a role for JNK1/2 in VCAM-1 induction in 
vascular cells [26;27]. However, it should be considered that different cell types, 
different experimental protocols, and different SP600125 concentrations may 
account for these discrepancies. TNF-α induced VCAM-1 expression depends 
on NFkB activation in endothelial cells [28]. EGCG did not affect IkB-α 
degradation nor NFkB activation after TNF-α stimulation in HAEC. This result 
strongly suggests that EGCG inhibits TF expression via a transcription factor 
other than NFkB and located downstream of JNK1/2, such as AP-1, which is 
known to regulate TF promoter activation [29]. 
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It is of clinical relevance that the inhibition of TF mRNA and protein 
expression reached a significant level when EGCG was applied at 
concentrations as low as 1 and 3 μM. Such levels of EGCG have been 
measured in human plasma following the oral intake of green tea extract or 
purified EGCG [30,31]. Thus, the inhibitory effect of 67LR activation by EGCG 
occurred at clinically relevant concentrations and might account at least in part 
for the cardioprotective effects of green tea consumption. 
In summary, this study demonstrates that 67LR activation by laminin or 
the polyphenol EGCG inhibits endothelial TF expression and activity. Hence, it 
describes a new mechanism by which the basement membrane modulates the 
hemostatic balance in intact vessels and identifies 67LR as a potential target for 
the development of novel anti-thrombotic therapies.  
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Figure Legends 
 
Figure 1: Laminin inhibits TF protein expression 
A. 67LR is abundantly expressed on the surface of HAEC. 20x 
magnification. B. TNF-α induced TF expression is inhibited when cells are 
grown on laminin as compared to fibronectin. *p<0.001. 
 
Figure 2: 67LR inhibits TF protein expression  
EGCG inhibits TNF-α (A) and histamine (B) induced TF protein expression 
in HAEC. *p<0.001 vs TNF-α and histamine alone. C. EGCG decreases TNF-α 
induced TF surface activity. *p<0.001 vs TNF-α alone. D. In C57BL6 mice 
EGCG reduces TF activity. *p<0.05 vs control. E. Treatment with a 67LR 
blocking antibody (MLUC5) abrogates the inhibitory effect of EGCG on TF 
expression. *p<0.01 vs TNF-α alone. All blots are normalized to GAPDH. 
 
Figure 3: 67LR inhibits TF promoter and TF mRNA expression 
A. Real-time PCR analysis demonstrates that EGCG impairs TF mRNA 
expression in HAEC. Values are normalized to L28 expression. *p<0.0001 vs 
TNF-α alone. B. Luciferase assay shows that EGCG inhibits TNF-α induced TF 
promoter activity. Values are normalized to total protein concentration. *p<0.001 
vs TNF-α alone. 
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Figure 4: EGCG impairs JNK1/2 phosphorylation 
A. TNF-α induces a transient phosphorylation of the MAP-kinases JNK, 
ERK, and p38. EGCG inhibits phosphorylation of JNK1/2, but not ERK and p38. 
No change in total expression of JNK, ERK, and p38 is observed. B. EGCG 
inhibits activation of JNK, but not ERK and p38. *p<0.01 vs TNF-α alone.  
 
Figure 5: 67LR activation mediates impairment of JNK1/2 activation by 
EGCG 
A. Transfection with siRNA against JNK1 and JNK2 mRNA inhibits TNF-α 
induced TF expression. *p<0.05 vs TNF-α alone. SP600125, a specific JNK 
inhibitor, impairs TF protein expression (B) and TF promoter activation (C). 
*p<0.001 vs TNF-α alone. D. Treatment with a 67LR blocking antibody blunts 
the inhibitory effect of EGCG on JNK activation. *p<0.001 vs TNF-α alone. 
 
Figure 6: Neither 67LR nor JNK regulate VCAM-1 expression 
A. Laminin does not alter TNF-α induced VCAM-1 expression in HAEC as 
compared to fibronection. p=NS. B. EGCG has no effect on TNF-α induced 
VCAM-1 expression. p=NS vs TNF-α alone. C. JNK inhibition with SP600125 
does not affect TNF-α induced VCAM-1 expression. p=NS vs TNF-α alone. All 
blots are normalized to GAPDH. 
 
 
 
 
 21
References 
 
[1] Mackman N, Tilley RE, Key NS. Role of the extrinsic pathway of blood 
coagulation in hemostasis and thrombosis. Arterioscler Thromb Vasc 
Biol. 2007; 27: 1687-93. 
[2] Steffel J, Luscher TF, Tanner FC. Tissue factor in cardiovascular 
diseases: molecular mechanisms and clinical implications. Circulation. 
2006; 113: 722-31. 
[3] Luscher TF, Steffel J, Eberli FR, Joner M, Nakazawa G, Tanner FC, et 
al. Drug-eluting stent and coronary thrombosis: biological mechanisms 
and clinical implications. Circulation. 2007; 115: 1051-8. 
[4] Toschi V, Gallo R, Lettino M, Fallon JT, Gertz SD, Fernandez-Ortiz A, et 
al. Tissue factor modulates the thrombogenicity of human atherosclerotic 
plaques. Circulation. 1997; 95: 594-9. 
[5] Davis GE, Senger DR. Endothelial extracellular matrix: biosynthesis, 
remodeling, and functions during vascular morphogenesis and neovessel 
stabilization. Circ Res. 2005; 97: 1093-07. 
[6] Liu Y, Senger DR. Matrix-specific activation of Src and Rho initiates 
capillary morphogenesis of endothelial cells. FASEB J. 2004; 18: 457-68. 
[7] Hallmann R, Horn N, Selg M, Wendler O, Pausch F, Sorokin LM. 
Expression and function of laminins in the embryonic and mature 
vasculature. Physiol Rev. 2005; 85: 979-1000. 
 22
[8] Nelson J, McFerran NV, Pivato G, Chambers E, Doherty C, Steele D, et 
al. The 67 kDa laminin receptor: structure, function and role in disease. 
Biosci Rep. 2008; 28: 33-48. 
[9] Gloe T, Riedmayr S, Sohn HY, Pohl U. The 67-kDa laminin-binding 
protein is involved in shear stress-dependent endothelial nitric-oxide 
synthase expression. J Biol Chem. 1999; 274: 15996-02. 
[10] Tachibana H, Koga K, Fujimura Y, Yamada K. A receptor for green tea 
polyphenol EGCG. Nat Struct Mol Biol. 2004; 11: 380-1. 
[11] Chyu KY, Babbidge SM, Zhao X, Dandillaya R, Rietveld AG, Yano J, et 
al. Differential effects of green tea-derived catechin on developing versus 
established atherosclerosis in apolipoprotein E-null mice. Circulation. 
2004; 109: 2448-53. 
[12] El Bedoui J, Oak MH, Anglard P, Schini-Kerth VB. Catechins prevent 
vascular smooth muscle cell invasion by inhibiting MT1-MMP activity and 
MMP-2 expression. Cardiovasc Res. 2005; 67: 317-25. 
[13] Kim JA, Formoso G, Li Y, Potenza MA, Marasciulo FL, Montagnani M, 
Quon MJ. Epigallocatechin gallate, a green tea polyphenol, mediates 
NO-dependent vasodilation using signaling pathways in vascular 
endothelium requiring reactive oxygen species and Fyn. J Biol Chem. 
2007; 282: 13736-45. 
[14] Lorenz M, Wessler S, Follmann E, Michaelis W, Dusterhoft T, Baumann 
G,et al. A constituent of green tea, epigallocatechin-3-gallate, activates 
endothelial nitric oxide synthase by a phosphatidylinositol-3-OH-kinase-, 
cAMP-dependent protein kinase-, and Akt-dependent pathway and leads 
 23
to endothelial-dependent vasorelaxation. J Biol Chem. 2004; 279: 6190-
5. 
[15] Stangl V, Dreger H, Stangl K, Lorenz M. Molecular targets of tea 
polyphenols in the cardiovascular system. Cardiovasc Res. 2007; 73: 
348-58. 
[16]    Lorenz M, Urban J, Engelhardt U, Baumann G, Stangl K, Stangl V. Green 
and black tea are equally potent stimuli of NO production and 
vasodilation: new insights into tea ingredients involved. Basic Res 
Cardiol. 2009; 104:100-10.  
[17] Debette S, Courbon D, Leone N, Gariepy J, Tzourio C, Dartigues JF, et 
al. Tea consumption is inversely associated with carotid plaques in 
women. Arterioscler Thromb Vasc Biol. 2008; 28: 353-59. 
[18] Kuriyama S, Shimazu T, Ohmori K, Kikuchi N, Nakaya N, Nishino Y, et 
al. Green tea consumption and mortality due to cardiovascular disease, 
cancer, and all causes in Japan: the Ohsaki study. JAMA. 2006; 296: 
1255-65. 
[19] Wolfram S. Effects of green tea and EGCG on cardiovascular and 
metabolic health. J Am Coll Nutr. 2007; 26: 373-88. 
[20] Gebhard C, Stämpfli SF, Gebhard CE, Akhmedov A, Breitenstein A, 
Camici GG, et al. Guggulsterone, an anti-inflammatory phytosterol, 
inhibits tissue factor and arterial thrombosis. Basic Res Cardiol. 2009; 
104: 285-94 
 24
[21] Holy EW, Akhmedov A, Luscher TF, Tanner FC. Berberine, a natural 
lipid-lowering drug, exerts prothrombotic effects on vascular cells. J Mol 
Cell Cardiol. 2009; 46: 234-40. 
[22] Böse D, Leineweber K, Konorza T, Zahn A, Bröcker-Preuss M, Mann K, 
et al. Release of TNF-alpha during stent implantation into saphenous 
vein aortocoronary bypass grafts and its relation to plaque extrusion and 
restenosis. Am J Physiol Heart Circ Physiol. 2007; 292:2295-99.  
[23] Parry GC, Mackman N. Transcriptional regulation of tissue factor 
expression in human endothelial cells. Arterioscler Thromb Vasc Biol. 
1995; 15: 612-21. 
[24] Givant-Horwitz V, Davidson B, Reich R. Laminin-induced signaling in 
tumor cells. Cancer Lett. 2005; 223: 1-10. 
[25] Steffel J, Arnet C, Akhmedov A, Iseli SM, Luscher TF, Tanner FC. 
Histamine differentially interacts with tumor necrosis factor-alpha and 
thrombin in endothelial tissue factor induction: the role of c-Jun NH2-
terminal kinase. J Thromb Haemost. 2006; 4: 2452-60. 
[26]  Bayat H, Xu S, Pimentel D, Cohen RA, Jiang B. Activation of thromboxane 
receptor upregulates interleukin (IL)-1beta-induced VCAM-1 expression  
through JNK signaling. Arterioscler Thromb Vasc Biol. 2008;28:127-34. 
[27] Lin SJ, Shyue SK, Hung YY, Chen YH, Ku HH, Chen JW, et al. 
Superoxide dismutase inhibits the expression of vascular cell adhesion  
molecule-1 and intracellular cell adhesion molecule-1 induced by tumor 
necrosis factor-alpha in human endothelial cells through the JNK/p38 
pathways. Arterioscler Thromb Vasc Biol. 2005;25:334-40. 
 25
[28] Zhou Z, Connell MC, MacEwan DJ. TNFR1-induced NF-kappaB, but not 
ERK, p38MAPK or JNK activation, mediates TNF-induced ICAM-1 and 
VCAM-1 expression on endothelial cells. Cell Signal. 2007;19:1238-48.  
[29] Liu Y, Pelekanakis K, Woolkalis MJ. Thrombin and tumor necrosis factor 
alpha synergistically stimulate tissue factor expression in human 
endothelial cells: regulation through c-Fos and c-Jun.J Biol Chem. 
2004;279: 36142-47. 
[30] Ullmann U, Haller J, Decourt JP, Girault N, Girault J, Richard-Caudron 
AS, et al. A single ascending dose study of epigallocatechin gallate in 
healthy volunteers. J Int Med Res. 2003; 31: 88-101. 
[31] Yang CS, Chen L, Lee MJ, Balentine D, Kuo MC, Schantz SP. Blood and 
urine levels of tea catechins after ingestion of different amounts of green 
tea by human volunteers. Cancer Epidemiol Biomarkers Prev. 1998; 7: 
351-54. 
 
 
